24 results on '"Rimel, Bobbie"'
Search Results
2. Sexual orientation and gender identity inequities in cervical cancer screening by race and ethnicity
3. Inequities in colorectal and breast cancer screening: At the intersection of race/ethnicity, sexuality, and gender
4. The association of black race with receipt of hysterectomy and survival in low-risk endometrial cancer
5. Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations
6. DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers
7. NRG‐GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.
8. Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer
9. Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
10. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study
11. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
12. Current gaps and opportunities in screening, prevention, and treatment of cervical cancer.
13. Breast Cancer Following Ovarian Cancer in BRCA Mutation Carriers
14. Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.
15. Cytochrome P450--inhibiting/inducing Medication Use Among Patients With Advanced Ovarian Cancer (aOC) Who Received or Were Eligible for Poly(ADP-ribose) Polymerase Inhibitors (PARPis) as First-line Maintenance Therapy.
16. Cytochrome P450 inhibiting/inducing medication use among patients with advanced ovarian cancer who receive or are eligible for poly (ADP-ribose) polymerase inhibitors as first line maintenance therapy (2200).
17. The American Society of Clinical Oncology 2017 Annual Meeting: A review and summary of selected abstracts.
18. Adnectin-Targeted Inhibitors: Rationale and Results.
19. Investigation of posttreatment NCCN surveillance adherence for patients with endometrial cancer who developed recurrence (1111).
20. P26 Mechanisms of response and resistance to epigenetic therapies in ovarian cancer.
21. Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.
22. Epigenetic mismatch repair deficiency in endometrioid endometrial cancer correlates with poor outcome (385).
23. A descriptive analysis of posttreatment retention of patients with vulvovaginal dysplasia and malignancies (505).
24. P10 Epigenetic mismatch repair deficiency in endometrioid endometrial cancer correlates with poor outcome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.